TKNO
Alpha Teknova Inc
NASDAQ: TKNO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$3.55
+9.91% today
Updated 2026-04-30
Market cap
$175.31M
P/E ratio
—
P/S ratio
4.33x
EPS (TTM)
$-0.32
Dividend yield
—
52W range
$2 – $7
Volume
0.1M
Alpha Teknova Inc (TKNO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-42.60%
Operating margin
-41.20%
ROE
-22.80%
ROA
-9.26%
Debt/equity
0.22x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $20.09M | $-1.30M | 42.67% | -9.24% | -6.49% |
| 2020 | $31.30M | $3.57M | 56.73% | 14.90% | 11.41% |
| 2021 | $36.89M | $-9.80M | 47.76% | -32.55% | -26.57% |
| 2022 | $41.42M | $-47.47M | 42.19% | -119.89% | -114.60% |
| 2023 | $36.68M | $-36.78M | 28.07% | -96.94% | -100.26% |
| 2024 | $37.74M | $-26.75M | 19.16% | -69.27% | -70.86% |
| 2025 | $40.52M | $-17.26M | 33.17% | -41.90% | -42.59% |